Lazard Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-140
Closed -$12K 2384
2025
Q2
$12K Buy
140
+113
+419% +$10.9K ﹤0.01% 2160
2025
Q1
$3K Buy
+27
New +$2.89K ﹤0.01% 2198
2024
Q3
Sell
-117
Closed -$12K 2476
2024
Q2
$12K Sell
117
-166
-59% -$19.6K ﹤0.01% 2040
2024
Q1
$37K Hold
283
﹤0.01% 1780
2023
Q4
$34K Hold
283
﹤0.01% 1996
2023
Q3
$31K Buy
283
+117
+70% +$14.9K ﹤0.01% 2018
2023
Q2
$24K Buy
166
+43
+35% +$5.84K ﹤0.01% 2073
2023
Q1
$15K Buy
123
+108
+720% +$13.6K ﹤0.01% 2099
2022
Q4
$1K Sell
15
-50
-77% -$5.8K ﹤0.01% 2348
2022
Q3
$6K Buy
65
+59
+983% +$6.47K ﹤0.01% 2181
2022
Q2
$0 Sell
6
-37
-86% -$4.39K ﹤0.01% 2603
2022
Q1
$5K Buy
+43
New +$5.18K ﹤0.01% 2185
2020
Q2
Sell
-22
Closed -$2K 1804
2020
Q1
$2K Hold
22
﹤0.01% 1548
2019
Q4
$3K Buy
+22
New +$3.04K ﹤0.01% 1462
2015
Q2
Sell
-19
Closed -$2K 1189
2015
Q1
$2K Buy
+19
New +$2.17K ﹤0.01% 1093
2014
Q4
Sell
-347
Closed -$33K 1173
2014
Q3
$33K Hold
347
﹤0.01% 935
2014
Q2
$35K Hold
347
﹤0.01% 948
2014
Q1
$31K Sell
347
-37
-10% -$3.41K ﹤0.01% 917
2013
Q4
$34K Sell
384
-94,798
-100% -$8.2M ﹤0.01% 920
2013
Q3
$7.59M Sell
95,182
-47,190
-33% -$3.71M 0.02% 418
2013
Q2
$10.4M Buy
+142,372
New +$10.6M 0.02% 354

Other funds holding ZBH

Lazard Asset Management's ZBH Position: Q3 2025 in Review

Lazard Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 140 shares — an estimated $12K sold.

Lazard Asset Management first reported a position in ZBH in Q2 2013 and held it in 21 quarters. The position peaked at $10.4M in Q2 2013. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Lazard Asset Management reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 140 Zimmer Biomet shares in Q3 2025, an estimated $12K.
  • Lazard Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 21 quarters.
  • Lazard Asset Management's Zimmer Biomet position peaked at $10.4M in Q2 2013.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.